Skip to main content
EnglishEnglish
EnglishEnglishArabicArabicChinese (Simplified)Chinese (Simplified)FrenchFrenchGermanGermanHindiHindiPortuguesePortugueseRussianRussianSpanishSpanishSwahiliSwahili

Header

  • Contact us
Home The Task Force for Global Health logo
  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep
Donate
Add a Program
Add a Program
Profile
Logout

Main navigation

  • About
    • Who we are
    • What we do
    • Our team
    • Technical Advisory Board
    • Executive Board
    • Donor Acknowledgements
  • Programs
    • Programs search
  • Data dashboards
  • Evidence base
    • All evidence (search)
      • Evidence Base Methodology
    • Action plans
    • Hepatitis B Birth Dose Vaccine
      • Synthesis Brief of Hepatitis B Birth Dose Evidence Base
    • HCV Testing
    • COVID-19
      • Clinical Liver Disease COVID-19 special series
        • The COVID-19 Pandemic: An Epidemiologic, Public Health, and Clinical Brief
        • Synthesis of Liver Associations Recommendations for Hepatology and Liver Transplant Care During the COVID-19 Pandemic
      • COVID-19 and Liver Disease Synthesis
    • Innovations in Hepatitis Elimination (CLD Series)
      • Author Interviews
      • Introduction to Series
      • Past Publications
      • Author Guidance
  • Resources
    • Hepatitis Elimination Help Desk
    • Search resources
  • Webinars
    • Hep Test
    • Strategic Information Collaborative
    • HepB Birth Dose Introduction in AFRO
    • Innovations in Hepatitis Elimination
    • NIH Research Advancing Hepatitis Elimination
  • Elimination champions
    • Elimination Champions
    • Nominations for Elimination Champions
  • News
    • News search
  1. Home
  2. Evidence base
  3. Evidence base search

Evidence base articles search

The evidence base was developed using rigorous review methods for the identification and quality assessment of eligible systematic reviews and guideline and policy documents. In response to identified global research priorities, the evidence base currently presents characteristics of interventions to inform implementation of hepatitis B birth dose and hepatitis B and C action plans. Updates to the evidence base are planned to address subsequent priorities.

Edit

Evidence base search

Filter

  • (-) HCV testing
  • Hepatitis B
  • Hepatitis C
  • HCV testing and linkage to Care
  • Linkage to care
  • Screening and diagnosis
  • Testing
  • General Population
  • Incarcerated populations (current and former)
  • Persons who inject drugs
  • Persons with substance use disorder
  • Cross-sectional
  • Prospective cohort
  • Retrospective cohort
  • (-) Australia
  • Laboratory-based antibody test
  • Laboratory-based antibody test,Laboratory-based PCR/RNA (confirmatory) test
  • Laboratory-based antibody test, Point-of-care PCR/RNA test
  • Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test)
  • Point-of-care antibody test (rapid test), Laboratory-based PCR/RNA (confirmatory) test
  • Point-of-care antibody test (rapid test), Point-of-care PCR/RNA test
  • Point-of-care PCR/RNA test
Displaying 1 - 8 of 8
  • Point-of-care hepatitis C testing from needle and syringe programs: An Australian feasibility study

    2019
    International Journal of Drug Policy

    72

    91-98
  • Opioid substitution therapy protects against hepatitis C virus acquisition in people who inject drugs: The HITS-c study

    2014
    Medical Journal of Australia

    201

    326-329
  • Hepatitis C testing and status among opioid substitution treatment clients in New South Wales

    2014
    Australian & New Zealand Journal of Public Health

    38

    160-164
  • Trends in prevalence of HIV infection, hepatitis B and hepatitis C among Australian prisoners - 2004, 2007, 2010

    2014
    Medical Journal of Australia

    200

    277-280
  • Blood-borne virus transmission in an urban, culturally diverse neighbourhood: Results from a cross-sectional bio-behavioural survey using innovative outreach methods in a hard-to-reach population

    2018
    Sexual Health

    15

    54-60
  • Uptake of hepatitis C treatment among people who inject drugs attending Needle and Syringe Programs in Australia, 1999-2011

    2014
    Journal of Viral Hepatitis

    21

    198-207
  • Estimating the cascade of hepatitis C testing, care and treatment among people who inject drugs in Australia

    2017
    International Journal of Drug Policy

    47

    77-85
  • Point-of-care Hepatitis C virus testing and linkage to treatment in an Australian inner-city emergency department

    2019
    International Journal of Drug Policy

    72

    84-90

Contact us

globalhep [at] taskforce.org

Tel: +1-404-371-0466

 

Photos on home page by Tayvessa Wilson, Conor Ashleigh, and Zunaid Murshed Paiker

Support us

Donate

Follow us

  • https://twitter.com/GlobalHep
  • https://www.facebook.com/GlobalHep/
  • https://vimeo.com/globalhep

Sign up to our newsletter

<

Footer

  • Contact
© 2019 - 2021 Coalition for Global Hepatitis Elimination
Website by Manta Ray Media
q